Functional regulation of human neutrophil Fc γ receptors

Immunologic Research

Volumn 29, Issue 1-3, 2004, Pages 219-229

  Selvaraj, Periasamy ^a   Fifadara, Nimita ^a   Nagarajan, Shanmugam ^a   Cimino, Ashley ^a   Wang, Guixian ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Avidity; CD16; CD32; GPI; ITAM; ITIM

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INOSITOL DERIVATIVE; INTERLEUKIN 3; INTERLEUKIN 5; MONOCLONAL ANTIBODY; TYROSINE;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; LIGAND BINDING; MOLECULAR INTERACTION; MONOCYTE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; RECEPTOR AFFINITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ERYTHROCYTES; HUMANS; LYMPHOCYTE ACTIVATION; MICE; NEUTROPHILS; RECEPTORS, IGG; ROSETTE FORMATION; SIGNAL TRANSDUCTION;

EID: 3042567401     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:29:1-3:219     Document Type: Review

References (69)

1. Kimberly RP, Wu J, Gibson AW, et al.: Diversity and duplicity: human Fc gamma receptors in host defense and autoimmunity. Immunol Res 2002;26:177-189.
2. Pritchard NR: B cell inhibitory receptors and autoimmunity. Immunology 2003;108:263-273.
3. Hogarth PM: Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr Opin Immunol 2002;14:798-802.
4. Salmon JE, Pricop L: Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001;44:739-750.
5. Ravetch JV, Bolland S: IgG Fc Receptors. Annu Rev Immunol 2001;19:275-290.
6. Raghavan M, Bjorkman PJ: Fc receptors and their interactions with immunoglobulins. Annu Rev Cell Biol 1996;12:181-220.
7. Unkeless JC, Scigliano E, Freedman VH: Structure and function of human and murine receptors for IgG. Annu Rev Immunol 1988;6:251-281.
8. Anderson CL, Looney RJ: Human leukocyte IgG Fc receptors. Immunol Today 1986;7:264-266.
9. Fanger MW, Shen L, Graziano RF, Guyre PM: Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today 1989;10:92-99.
10. Malavasi F, Tetta C, Funaro A, et al.: Fc receptor triggering induces expression of surface activation antigens and release of platele-activating factor in large granular lymphocytes. Proc Natl Acad Sci USA 1986;83:2443-2447.
11. Cassatella MA, Anegon I, Cuturi MC, Griskey P, Trinchieri G, Perussia B: Fc gamma R (CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. J Exp Med 1989;169:549-567.
12. Frank MM, Hamburger MI, Lawley T, Kimberly RP, Plotz PH: Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979;300:518-523.
13. Clark MR, Liu L, Clarkson SB, Ory PA, Goldstein IM: An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. J Clin Invest 1990;86:341-346.
14. Frank MM, Lawley TJ, Hamburger MI, Brown EJ: Immunoglobulin G Fc receptor-mediated clearence in autoimmune diseases. Ann Intern Med 1983;98:206-218.
15. Lawley TJ, Hall RP, Fauci AS, Katz SI, Hamburger MI, Frank MM: Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype. Studies in patients with dermatitis herpetiformis and normal subjects. N Engl J Med 1981;304:185-192.
16. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV: FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994;76:519-529.
17. Ravetch JV, Clynes RA: Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 1998;16:421-432.
18. Hazenbos WL, Gessner JE, Hofhuis FM, et al.: Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 1996;5:181-188.
19. Ravetch JV, Kinet J-P: Fc Receptors. Annu Rev Immunol 1991;9:457-492.
20. Nag B, Wada HG, Passmore D, Clark BR, Sharma SD, McConnell HM: Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells. J Immunol 1993;150:1358-1364.
21. Hulett M,D., Hogarth PM: Molecular basis of Fc receptor function. Adv Immunol 1994;57:1-127.
22. Unkeless JC, Shen Z, Lin C, DeBeus E: Function of human FcγRIIA and FcγRIIIB. Sem Immunol 1995;7:37-44.
23. Indik ZK, Park JG, Hunter S, Schreiber AD: Structure/function relationships of Fc gamma receptors in phagocytosis. Sem Immunol 1995;7:45-54.
24. Brooks DG, Qui WQ, Luster AD, Ravetch JV: Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J Exp Med 1989;170:1369-1385.
25. Werner G, Von dem Borne AEG, Bos MJE, et al: Localization of NA1 alloantigen on neutrophil Fcg receptors. In Leukocyte Typing II. (Reinherz EL, Haynes BF, Nadler LM, Bernstein ID, eds.). Springer-Verlag, New York, 1986, pp. 109-121.
26. Selvaraj P, Rosse WF, Silber R, Springer TA: The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal hemoglobinuria. Nature 1988;333:565-567.
27. Selvaraj P, Carpen O, Hibbs ML, Springer TA: Natural Killer cell and granulocyte FcγRIII (CD16) differ in membrane anchor and signal transduction. J Immunol 1989;143:3283-3288.
28. Lanier LL, Phillips JH, Testi R: Membrane anchoring and spontaneous release of CD16 (FcγR III) by natural killer cells and granulocytes. Eur J Immunol 1989;19:775-778.
29. Ravetch JV, Perussia B: Alternative membrane forms of Fc gamma RIII (CD16) on human NK cells and neutrophils: Cell-type specific expression of two genes which differ in single nucleotide substitutions. J Exp Med 1989;170:481-497.
30. Scallon BJ, Scigliano E, Freedman VH, et al.: A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol- glycananchored forms. Proc Natl Acad Sci USA 1989;86:5079-5083.
31. Edberg JC, Redecha PB, Salmon JC, Kimberly RP: Human FcγRIII (CD16): isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells. J Immunol 1989;143:1642-1649.
32. Ueda E, Kinoshita T, Nojima J, Inoue K, Kitani T: Different membrane anchors of Fc gamma RIII (CD16) on K/NK-lymphocytes and neutrophils proteins- vs lipid-anchor. J Immunol 1989;143:1274-1277.
33. Simmons D, Seed B: The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein. Nature 1988;333:568-570.
34. Nagarajan S, Chesla SE, Cobern L, Anderson P, Zhu C, Selvaraj P: Ligand binding and phagocytosis by CD16 (Fc gamma receptor III) isoforms. J Biol Chem 1995;270:25762-25770.
35. Lanier LL, Ruitenberg JJ, Phillips JH: Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol 1988;141:3478-3485.
36. Kimberly RP, Ahlstrom JW, Click ME, Edberg JC: The glycosyl phosphatidylinositol-linked FcγRIII PMN mediates transmembrane signaling events distinct from FcγRII. J Exp Med 1990;171:1239-1255.
37. Huizinga TWJ, Dolman KM, Van Der Linden NJM, et al.: Phosphatidylinositol-linked FcγRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J Immunol 1990;144:1432-1437.
38. Hibbs ML, Selvaraj P, Carpen O, et al.: Mechanism regulating expression of membrane isoforms of FcγRIII (CD16). Science 1989;246:1608-1611.
39. Anderson P, Caligiuri M, O'Brien C, Manley T, Ritz J, Schlossman SF: Fcγ Receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. Proc Natl Acad Sci USA 1990;87:2274-2278.
40. Lanier LL, Yu G, Phillips JH: Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 1989:342:803-805.
41. Yuasa T, Kubo S, Yoshino T, et al.: Deletion of Fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 1999;189:187-194.
42. Clynes R, Maizes JS, Guinamard R, Ono M, Takai T, Ravetch JV: Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999;189:179-185.
43. Bolland S, Ravetch JV: Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol 1999;72:149-177.
44. Anderson CL, Shen L, Eicher DM, Wewers MD, Gill JK: Phagocytosis mediated by three distinct Fcγ receptor classes on human leukocytes. J Exp Med 1990;171:1333-1345.
45. Edberg JC, Kimberly RP: Modulation of Fcγ and complement receptor function by the glycosyl-phosphatidylinositol-anchored form of FcγRIII. J Immunol 1994;152:5826-5835.
46. Nagarajan S, Venkiteswaran K, Anderson M, Sayed U, Zhu C, Selvaraj P: Cell specific, activation dependent regulation of neutrophil CD32A ligand binding function. Blood 2000;95:1069-1077.
47. Springer TA: Adhesion receptors of the immune system. Nature 1990:346:425-434.
48. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
49. Dustin ML, Springer TA: T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989;341:619-624.
50. Kishmoto TK, Larson RS, Corbi AL, Dutstin ML, Stauton DE, Springer TA: The leukocyte integrins. Adv Immunol 1990;46:149-182.
51. Miller KL, Duchemin A, Anderson CL: A novel role for the Fc receptor γ subunit: enhancement of FcγR ligand affinity. J Exp Med 1996;183:2227-2233.
52. Koenderman L, Hermans SWG, Capel JA, Van de Winkel JGJ: Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFcγRII, on human eosinophils. Blood 1993;81:2413-2419.
53. Chuang FY, Sassaroli M, Unkeless JC: Convergence of Fc gamma receptor IIA and Fc gamma receptor IIIB signaling. J Immunol 2000;164:350-360.
54. Salmon JE, Millard SS, Brogle NL, Kimberly RP: Fcγ receptor IIIb enhances Fcγ receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 1995;95:2877-2885.
55. Salmon JE, Brogle NL, Edberg JC, Kimberly RP: Fcγ receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fcγ receptor II. J Immunol 1991;146:997-1004.
56. Anderson CL, Spence JM, Edwards TS, Nusbacher J: Characterization of a polyvalent antibody directed against the IgG Fc receptor of human mononuclear phagocytes. J Immunol 1985;134:465-470.
57. Huizinga TWJ, Dolman KM, van Der Linden NMJ, et al.: Phosphatidylinositol-linked FcγRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J Immunol 1990;144:1432-1437.
58. Tax WJM, Van de Winkel JGJ: Human Fcγ receptor II: a standby receptor activated by proteolysis? Immunol Today 1990;11:308-310.
59. Trevani AS, Andonegui GA, Istruriz MA, Schatner M, Serebrinsky G, Gefner JR: Effect of proteolytic enzymes on neutrophil FcγRII activity. Immunology 1994;82:632-637.
60. Kallenberg CG, Heeringa P: Pathogenesis of vasculitis. Lupus 1998;7:280-284.
61. Salmon JE, Millard S, Schachter LA, et al.: FcγRIIA alleles are heritable risk factors for Lupus nephritis in African americans. J Clin Invest 1996;97:1348-1354.
62. Lassmann H, Bruck W, Lucchinetti C: Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001;7:115-121.
63. Bredius RGM, Fijen CAP, DeHaas M, et al.: Role of neutrophil Fc-gamma RIIa (CD32) and Fc-gammaR IIIb (CD16) polymorphic in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 1994;83:624-630.
64. Fijen CAP, Bredius RGM, Kuijper EJ: Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med 1993;119:636.
65. Sanders LAM, van de Winkel JGL, Rukers GT, et al.: Fc gamma receptor lia (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 1994;170:854-861.
66. Yee AMF, Phan HM, Zuniga R, Salmon JE, Musher DM: Association between FcγRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis 2000;30:25-28.
67. Rascu A, Repp R, Westerdaal NAC, Kalden JR, Van de Winkel JGJ: Clinical relevance of Fcγ receptor polymorphisms. Ann NY Acad Sci 1997;815:282-295.
68. Chang DJ: Differential regulation of Fcgamma receptor isoforms: implications for therapeutic interventions. Am J Ther 1995;2:777-781.
69. Johnson P: The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol 2003;30:3-8.